GlassScriptPhysician profile
Donna M Witkins
NPI 1649795055
$19,059.71
in general payments reported to CMS, 2019-2025
44 companies · $4,458 in 2025
The $4,458 reported for 2025 was more than what 98% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,818 · 2022: $3,213 · 2023: $3,590 · 2024: $4,981 · 2025: $4,458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Education: $798 · Consulting Fee: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,081.01 |
| Education | $798.27 |
| Consulting Fee | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $4,393.12 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $3,292.76 | 2021-2025 | Airsupra, Tezspire, Breztri |
| Genzyme Corporation | $1,652.11 | 2022-2025 | |
| Harmony Biosciences LLC | $1,420.69 | 2021-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $950.64 | 2021-2025 | |
| Actelion Pharmaceuticals US, INC. | $928.29 | 2021-2025 | Opsumit, Uptravi, Opsynvi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $895.18 | 2021-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Baxter Healthcare | $670.64 | 2022-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Monarch Airway Clearance System, Actifuse |
| Regeneron Healthcare Solutions, INC. | $625.41 | 2021-2025 | Dupixent |
| Amgen INC. | $595.20 | 2021-2025 | Tezspire, Tavneos |
| Electromed, INC. | $457.61 | 2023-2025 | Smartvest |
| Mylan Specialty L.P. | $371.36 | 2021-2024 | Yupelri |
| Mallinckrodt Hospital Products INC. | $338.00 | 2021-2023 | Acthar |
| Takeda Pharmaceuticals U.S.A., INC. | $293.69 | 2021-2025 | Glassia |
| Verona Pharma, INC. | $232.34 | 2025 | Ohtuvayre |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $227.33 | 2022-2023 | Quviviq |
| Axsome Therapeutics, INC. | $195.83 | 2024-2025 | Sunosi |
| E.R. Squibb & Sons, L.L.C. | $175.53 | 2021-2023 | Eliquis |
| Arbor Pharmaceuticals, INC. | $175.21 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $105.75 | 2021-2022 | |
| Ani Pharmaceuticals, INC. | $101.70 | 2023 | Purified Cortrophin Gel |
| Philips North America LLC | $101.29 | 2022-2024 | (O58) Sleep Respiratory Care Und |
| Genentech USA, INC. | $90.62 | 2021-2023 | Esbriet, Xolair |
| Novartis Pharmaceuticals Corporation | $88.71 | 2023-2024 | |
| Lilly USA, LLC | $70.57 | 2025 | Zepbound, Mounjaro |
| Covis Pharma Gmbh | $69.99 | 2022-2023 | |
| Zoll Respicardia, INC. | $66.47 | 2024 | Remede System |
| Avadel Cns Pharmaceuticals, LLC | $60.92 | 2024-2025 | Lumryz |
| Inogen, INC. | $58.34 | 2024-2025 | |
| 3b Medical, INC. | $47.95 | 2025 | Luna |
| Nabriva Therapeutics, Plc | $33.45 | 2021-2022 | |
| Paratek Pharmaceuticals, INC. | $31.12 | 2023 | Nuzyra |
| Vifor Pharma, INC. | $27.30 | 2025 | Veltassa |
| Viatris Specialty LLC | $26.58 | 2025 | Yupelri |
| Pulmonx Corporation | $24.85 | 2024 | Chartis Catheter, Zephyr Endobronchial Valve, Zephyr Delivery Catheter |
| Invivyd INC | $21.94 | 2025 | Pemgarda |
| Medtronic, INC. | $20.29 | 2023 | Interstim |
| Eisai INC. | $18.31 | 2022 | |
| Azurity Pharmaceuticals, INC. | $17.71 | 2025 | Horizant |
| Inspire Medical Systems, INC. | $17.52 | 2025 | Inspire |
| Merck Sharp & Dohme LLC | $17.45 | 2023 | |
| Novo Nordisk INC | $17.42 | 2023 | Ozempic, Rybelsus |
| Pfizer INC. | $17.08 | 2025 | |
| Hikma Pharmaceuticals USA | $15.44 | 2023 | Ryaltris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Witkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.